Structure of the adriamycin-cardiolipin complex. Role in mitochondrial toxicity.
暂无分享,去创建一个
[1] N. Toshiharu,et al. Elevation of blood pressure in young rats fed a low calcium diet. Effects of nifedipine and captopril. , 1989 .
[2] R. Brasseur,et al. Study of the adriamycin-cardiolipin complex structure using attenuated total reflection infrared spectroscopy. , 1987, Biochemistry.
[3] E. Goormaghtigh,et al. In vivo and in vitro modifications of the mitochondrial membrane induced by 4' Epi-adriamycin. , 1986, Biochemical pharmacology.
[4] A. Garnier-Suillerot,et al. Interaction of adriamycin with cardiolipin-containing vesicles. Evidence of an embedded site for the dihydroanthraquinone moiety. , 1986, Biochimica et biophysica acta.
[5] J. Bolard,et al. Interaction of adriamycin with negatively charged model membranes: evidence of two types of binding sites. , 1985, Biochemistry.
[6] T. Burke,et al. Location and dynamics of anthracyclines bound to unilamellar phosphatidylcholine vesicles. , 1985, Biochemistry.
[7] T. Burke,et al. Structural basis of anthracycline selectivity for unilamellar phosphatidylcholine vesicles: an equilibrium binding study. , 1985, Biochemistry.
[8] E. Goormaghtigh,et al. Damages of the mitochondrial membrane in Adriamycin treated mice. , 1984, Cancer letters.
[9] E. Goormaghtigh,et al. Anthracycline glycoside-membrane interactions. , 1984, Biochimica et biophysica acta.
[10] M. Müller,et al. The mitochondrial phosphate carrier reconstituted in liposomes is inhibited by doxorubicin , 1983, FEBS letters.
[11] B. Kadenbach,et al. Specific and reversible activation and inactivation of the mitochondrial phosphate carrier by cardiolipin and nonionic detergents, respectively , 1983, FEBS letters.
[12] H. Nohl,et al. OH.-generation by adriamycin semiquinone and H2O2; an explanation for the cardiotoxicity of anthracycline antibiotics. , 1983, Biochemical and biophysical research communications.
[13] E. Goormaghtigh,et al. Role of the quinone structure in the mitochondrial damage induced by antitumor anthracyclines , 1983, FEBS letters.
[14] J. Doroshow,et al. Mitochondrial NADH dehydrogenase‐catalyzed oxygen radical production by adriamycin, and the relative inactivity of 5‐iminodaunorubicin , 1983, FEBS letters.
[15] E. Goormaghtigh,et al. Mitochondrial membrane modifications induced by adriamycin-mediated electron transport. , 1983, Biochemical pharmacology.
[16] E. Goormaghtigh,et al. Adriamycin inhibits the formation of non-bilayer lipid structures in cardiolipin-containing model membranes. , 1982, Biochimica et biophysica acta.
[17] R. Brasseur,et al. Adriamycin inactivates cytochrome c oxidase by exclusion of the enzyme from its cardiolipin essential environment. , 1982, Biochemical and biophysical research communications.
[18] E Goormaghtigh,et al. Theoretical conformational analysis of phospholipids bilayers. , 1981, Biochemical and biophysical research communications.
[19] E. Bertoli,et al. Incorporation of ubiquinone homologs into lipid vesicles and mitochondrial membranes. , 1981, Archives of biochemistry and biophysics.
[20] E. Goormaghtigh,et al. Lipid—drug electrostatic interactions in model membranes , 1981 .
[21] D. E. Green,et al. Cardiolipin requirement for electron transfer in complex I and III of the mitochondrial respiratory chain. , 1981, The Journal of biological chemistry.
[22] T. Lampidis,et al. Structural and functional effects of adriamycin on cardiac cells in vitro. , 1980, Cancer research.
[23] E. Goormaghtigh,et al. Evidence of a complex between adriamycin derivatives and cardiolipin: possible role in cardiotoxicity. , 1980, Biochemical pharmacology.
[24] D. E. Green,et al. Cardiolipin requirement by cytochrome oxidase and the catalytic role of phospholipid. , 1980, Biochemical and biophysical research communications.
[25] E. Goormaghtigh,et al. Evidence of a specific complex between adriamycin and negatively-charged phospholipids. , 1980, Biochimica et biophysica acta.
[26] G. Karczmar,et al. The interaction of adriamycin with small unilamellar vesicle liposomes. A fluorescence study. , 1979, Biochimica et biophysica acta.
[27] M. Seraydarian,et al. Modification by adenosine of the effect of adriamycin on myocardial cells in culture. , 1979, Cancer research.
[28] A. Verkleij,et al. Polymorphic phase behaviour of cardiolipin as detected by 31P NMR and freeze-fracture techniques. Effects of calcium, dibucaine and chlorpromazine. , 1978, Biochimica et biophysica acta.
[29] R. Goldman,et al. A differential interaction of daunomycin, adriamycin and their derivatives with human erythrocytes and phospholipid bilayers. , 1978, Biochimica et biophysica acta.
[30] N. Bachur,et al. Anthracycline antibiotic augmentation of microsomal electron transport and free radical formation. , 1977, Molecular pharmacology.
[31] H. M. Sobell,et al. Visualization of drug-nucleic acid interactions at atomic resolution. II. Structure of an ethidium/dinucleoside monophosphate crystalline complex, ethidium:5-iodocytidylyl (3'-5') guanosine. , 1977, Journal of molecular biology.
[32] H. M. Sobell,et al. Visualization of drug-nucleic acid interactions at atomic resolution. I. Structure of an ethidium/dinucleoside monophosphate crystalline complex, ethidium:5-iodouridylyl (3'-5') adenosine. , 1977, Journal of molecular biology.
[33] J. Ruysschaert,et al. Affinity of adriamycin to phospholipids. A possible explanation for cardiac mitochondrial lesions. , 1976, Biochemical and biophysical research communications.
[34] B. Chance,et al. Effects of anticancer agents on the respiration of isolated mitochondria and tumor cells. , 1974, European journal of cancer.
[35] F. L. Crane,et al. Four quinone reduction sites in the NADH dehydrogenase complex. , 1970, Biochemical and biophysical research communications.
[36] R. Brasseur,et al. Mechanism of inhibition of mitochondrial enzymatic complex I-III by adriamycin derivatives. , 1986, Biochimica et biophysica acta.
[37] H M Berman,et al. The interaction of intercalating drugs with nucleic acids. , 1981, Annual review of biophysics and bioengineering.